S. 488 · 111th Congress
Access to Cancer Clinical Trials Act of 2009
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 111th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
BrownSponsor3 cosponsors · 1 D, 1 R, 1 I
0 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Access to Cancer Clinical Trials Act of 2009 - Amends the Public Health Service Act, the Employee Retirement Income Security Act of 1974 (ERISA), and the Internal Revenue Code to prohibit a group health plan from: (1) denying an eligible participant or beneficiary with cancer participation in clinical trials related to the prevention or treatment of cancer…
What it does: CRS summary · Introduced in Senate · Feb 26, 2009
Access to Cancer Clinical Trials Act of 2009 - Amends the Public Health Service Act, the Employee Retirement Income Security Act of 1974 (ERISA), and the Internal Revenue Code to prohibit a group health plan from: (1) denying an eligible participant or beneficiary with cancer participation in clinical trials related to the prevention or treatment of cancer that are federally funded or conducted under an investigational new drug application reviewed by the Food and Drug Administration (FDA); (2) denying (or limiting or imposing additional conditions on) the coverage of routine patient costs for items and services furnished in connection with such participation; or (3) discriminating against an individual on the basis of such participation. Includes as routine patient costs all items and services provided in the clinical trial that are otherwise generally available to a qualified individual, with certain exceptions.
Applies such prohibitions to coverage offered in the individual market and coverage offered through the Federal Employees Health Benefits Program.
Makes this Act effective January 1, 2009.
Requires the Secretary of Health and Human Services to study the impact on group health plans of requiring them to cover routine patient care costs for individuals with serious and life threatening diseases other than cancer.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Access to Cancer Clinical Trials Act of 2009
Latest action (Feb 26, 2009): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Policy area: Health · Origin: Senate · Introduced: Feb 26, 2009
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.